Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02206100
What this trial is testing

PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin

Who this might be right for
Healthy
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 40
Early research (Phase 1)Study completedNCT05960240
What this trial is testing

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Who this might be right for
Chronic Hepatitis b
Arbutus Biopharma Corporation 128
Testing effectiveness (Phase 2)Looking for participantsNCT07308548
What this trial is testing

A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )

Who this might be right for
NAFLD (Non-alcoholic Fatty Liver Disease)
Hinova Pharmaceuticals Inc. 80
Early research (Phase 1)Study completedNCT04554043
What this trial is testing

The PK/PD Study of SHR7280 Tablets in Healthy Subjects.

Who this might be right for
Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd. 118
Early research (Phase 1)Study completedNCT05897008
What this trial is testing

The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity

Who this might be right for
Healthy Volunteers
Taizhou Mabtech Pharmaceutical Co.,Ltd 114
Early research (Phase 1)Study completedNCT02135640
What this trial is testing

China HVT Safety, PK, PD

Who this might be right for
Osteoporosis
GlaxoSmithKline 64
Early research (Phase 1)Study completedNCT01147588
What this trial is testing

Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

Who this might be right for
Healthy
AstraZeneca 149
Early research (Phase 1)Study completedNCT01872572
What this trial is testing

Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD

Who this might be right for
Healthy Volunteer
Regado Biosciences, Inc. 36
Early research (Phase 1)Ended earlyNCT04941183
What this trial is testing

Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients

Who this might be right for
Covid19
Neutrolis 52
Testing effectiveness (Phase 2)Ended earlyNCT03605212
What this trial is testing

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults

Who this might be right for
Tumor Lysis Syndrome
Menarini Group 30
Early research (Phase 1)Ended earlyNCT02058407
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects

Who this might be right for
Bronchiectasis
GlaxoSmithKline 33
Early research (Phase 1)Study completedNCT06044467
What this trial is testing

The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects

Who this might be right for
Nonalcoholic Fatty Liver Disease
ChemomAb Ltd. 16
Early research (Phase 1)UnknownNCT03668509
What this trial is testing

Safety, Tolerability and PK/PD of SHR1459 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Jiangsu HengRui Medicine Co., Ltd. 30
Early research (Phase 1)Study completedNCT02202213
What this trial is testing

Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 47
Testing effectiveness (Phase 2)UnknownNCT05753462
What this trial is testing

Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Sqy Therapeutics 12
Testing effectiveness (Phase 2)Ended earlyNCT04247594
What this trial is testing

Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD

Who this might be right for
Sickle Cell Disease
Pfizer 6
Early research (Phase 1)Ended earlyNCT05162131
What this trial is testing

Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers

Who this might be right for
Healthy
SFJ Pharmaceuticals, Inc. 34
Testing effectiveness (Phase 2)Study completedNCT03020745
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects

Who this might be right for
Hepatitis B
GlaxoSmithKline 78
Early research (Phase 1)Study completedNCT06480981
What this trial is testing

Multiple Ascending Dose Noribogaine PK/PD in Healthy Volunteers

Who this might be right for
Pharmacokinetics
DemeRx NB 55
Early research (Phase 1)Study completedNCT06727396
What this trial is testing

Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

Who this might be right for
Healthy Subjects
Chong Kun Dang Pharmaceutical 44
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation